J.-J. Patard

Bicêtre Hospital

Papers

2

Total Citations

301

H-Index

2

About

Jean-Jacques Patard is a leading figure in urologic oncology, renowned for his expertise in renal cell carcinoma (RCC) and surgical management of kidney tumors. His most impactful contribution is co-authoring the ESMO Clinical Practice Guidelines for RCC, which have garnered over 275 citations and serve as a global reference for diagnosis, treatment, and follow-up strategies. Patard’s work bridges evidence-based medicine and clinical practice, particularly in refining surgical techniques and outcomes. His study on predictive factors of hemorrhagic complications after partial nephrectomy (26 citations) underscores his commitment to improving patient safety and surgical precision. Beyond these papers, Patard has published extensively on prognostic models, targeted therapies, and minimally invasive surgery for RCC, shaping modern urologic care. His research is widely cited by clinicians and researchers alike, reflecting its practical impact on patient management. Patard’s contributions have earned him recognition as a key opinion leader in urologic oncology, and his guidelines remain a cornerstone for trainees and specialists navigating the complexities of renal cancer treatment.

Research Focus

Key Achievements

2
H-Index
2
Papers
301
Total Citations
151
Avg Citations/Paper
🏆 Most Cited Paper
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
275 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Bicêtre Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago